Want to join the conversation?
Specialty biopharmaceutical company $MNK announced results from an analysis of health economic data on the use of OFIRMEV injection as part of multimodal analgesia (MMA) for the treatment of acute postoperative pain following elective orthopedic surgery. This analysis could offer ways to improve hospital system savings, as well as patient outcomes.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?